ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1343

Mortality Due to Sepsis in Patients with Rheumatoid Arthritis

Orit Barrett1, Ella Abramovich2, Jacob Dreiher3, Victor Novack4 and Mahmoud Abu-Shakra5, 1Department of Medicine D, Soroka Medical Center and Ben-Gurion University, Beersheba, Israel, 2Department of Medicine D, Soroka University Medical Center and Ben-Gurion University, Beersheba, Israel, 3Clalit Health Services, Ben-Gurion University of the Negev, Beer Sheva,,, BeerSheba, Israel, 4Clinical Research Center, Soroka Medical Center and Ben-Gurion University, Beersheba, Israel, 5Rheumatic Diseases Unit, Soroka Medical Center and Ben-Gurion University, Beer-Sheva, Israel

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Infection, morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease: Poster Session

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Severe infections contribute significantly to the morbidity and mortality of patients with rheumatoid arthritis.

The aim of the study was to  identify the characteristics of patients with  RA who were admitted to intensive care unit (ICU) with Sepsis,  to determine whether RA is an independent risk factors for short- and long-term mortality in patients admitted to the ICU with sepsis and to identify variables associated with mortality among patients with  RA

Methods: The study was based on the data of SEPSIS-ISR, an ongoing prospective study that collects data on all patients admitted the ICUs with the diagnosis of sepsis. 124 patients with RA and sepsis were found in the database.

Controls:  Age-and-gender matched controls who were admitted to the ICU with diagnosis of Sepsis were selected in a ratio of 2:1.

Results: The mean age of the patients with RA and control was 71 years with 65% of them were women. The main comorbidity included hypertension (77%), diabetes mellitus (57%), congestive heart failure (35%), renal failure (35%), and chronic lung disease (27%).

Severe sepsis and septic shock were diagnosed in 92% vs. 84% (P=0.032) and 50% vs. 39% (P=0.059) in the RA patients and controls respectively. Pneumonia (35% vs. 30%) and urinary tract infection (9% vs. 15%) were the most common site of infection.

The 30 days mortality was 48% vs. 43% (P=0.37) in the RA and controls and the 3 years survival was 18% vs. 30% in the RA patients vs. controls (P=0.02).

In univariate analyses Variables associate with 3 years mortality included: RA (OR=2.2, P=0.009), CHF (OR=5.3 P=0.001), DM (OR=2.4 P=0.002), Charlson’s Score (OR=1.6 P=0.001), HTN (OR=1.86 P=0.036) and age (OR=1.03, P=0.017)

Multivariate analyses revealed that RA (OR=3.66 P=0.005) and Charlson’s score (OR=1.9 P=0.001) were the only variables associated with 3 years mortality

Conclusion: RA is an independent risk factor for adverse results in sepsis including sever sepsis, septic shock and 3 years mortality. Long term survival of patients with RA admitted to the ICU with sepsis is related to higher Charlson’s score. Other factors associated with higher mortality rates among patients with sepsis includes CHF, DM, HTN and advanced age.


Disclosure: O. Barrett, None; E. Abramovich, None; J. Dreiher, None; V. Novack, None; M. Abu-Shakra, None.

To cite this abstract in AMA style:

Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M. Mortality Due to Sepsis in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mortality-due-to-sepsis-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mortality-due-to-sepsis-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology